About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (11)
Ashley ClarkeACA
Chief Financial Officer & Company Secretary
ImmuPharma
team_memberexecutive
Dr Laurence ReillyMBA
Senior Independent Non-Executive Director
ImmuPharma
team_member
Dr Sébastien R
Chief Scientific Officer
ImmuPharma
executive
Dr Tim FranklinPhD
Chief Operating Officer
ImmuPharma
executive
Ketan Patel
Independent Non-Executive Director
ImmuPharma
team_member
Laura Mauran-AmbrosinoPh
Head of R&D
ImmuPharma
team_member
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
468
By Phase
NA: 3PHASE3: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 6
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05192720Collaborator
Andosan in Allergic and Asthma Patients
NACompleted
34 participants
Started: Aug 31, 2021 · Completed: Feb 28, 2023
NCT03427151Lead Sponsor
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
PHASE3Completed
62 participants
Started: Feb 27, 2018 · Completed: Feb 5, 2019
NCT01815411Collaborator
Effect of Andosan in Patients With Rheumatoid Arthritis
NACompleted
10 participants
Started: May 31, 2016 · Completed: Apr 30, 2018
NCT03198455Collaborator
Does Medicinal Mushroom Agaricus Blazei Protect Against Allergy and Asthma?
NACompleted
60 participants
Started: Feb 29, 2016 · Completed: Oct 31, 2016
NCT02504645Lead Sponsor
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
PHASE3Completed
202 participants
Started: Mar 31, 2015 · Completed: Jan 31, 2018
Locations (1)
Headquarters
London, UK
Map
Loading map...